These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 26456846)

  • 1. Functional promoter polymorphisms of the receptor for advanced glycation end products in children and adolescents with type 1 diabetes.
    Gomes LC; Welter M; Gobor LC; Santos-Weiss ICR; França SN; Alberton D; Picheth G; Rego FG
    Mol Cell Probes; 2015 Dec; 29(6):503-506. PubMed ID: 26456846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of RAGE gene polymorphism with circulating AGEs level and paraoxonase activity in relation to macro-vascular complications in Indian type 2 diabetes mellitus patients.
    Bansal S; Chawla D; Banerjee BD; Madhu SV; Tripathi AK
    Gene; 2013 Sep; 526(2):325-30. PubMed ID: 23721855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The functional polymorphisms -429T>C and -374T>A of the RAGE gene promoter are not associated with gestational diabetes in Euro-Brazilians.
    Santos IC; Daga DR; Frigeri HR; Réa RR; Almeida AC; Souza EM; Pedrosa FO; Fadel-Picheth CM; Picheth G
    Genet Mol Res; 2010 Jun; 9(2):1130-5. PubMed ID: 20568058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Association of -429T>C and -374T>A Polymorphisms in the RAGE Gene with Polycystic Ovary Syndrome.
    Park JH; Li L; Choi JW; Baek KH
    Int J Med Sci; 2016; 13(6):451-6. PubMed ID: 27279795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms of the promoter and exon 3 of the receptor for advanced glycation end products (RAGE) in Euro- and Afro-Brazilians.
    Torres MC; Beltrame MH; Santos IC; Picheth G; Petzl-Erler ML; Pedrosa FO; Steffens MB; de Souza EM
    Int J Immunogenet; 2012 Apr; 39(2):155-60. PubMed ID: 22133449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The -374A allele of the receptor for advanced glycation end products (RAGE) gene promoter is a protective factor against cardiovascular lesions in type 2 diabetes mellitus patients.
    Picheth G; Costantini CO; Pedrosa FO; Leme da Rocha Martinez T; Maltempi de Souza E
    Clin Chem Lab Med; 2007; 45(10):1268-72. PubMed ID: 17924846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms of the receptor for advanced glycation end-products and glyoxalase I in patients with renal cancer.
    Chocholatý M; Jáchymová M; Schmidt M; Havlová K; Křepelová A; Zima T; Babjuk M; Kalousová M
    Tumour Biol; 2015 Mar; 36(3):2121-6. PubMed ID: 25407489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional polymorphisms of the receptor for the advanced glycation end product promoter gene in inflammatory bowel disease: a case-control study.
    Ciccocioppo R; Bozzini S; Betti E; Imbesi V; Klersy C; Lakyova LS; Sukovsky L; Benacka J; Kruzliak P; Corazza GR; Di Sabatino A; Falcone C
    Clin Exp Med; 2019 Aug; 19(3):367-375. PubMed ID: 31175506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association study of polymorphisms in the receptor for advanced glycation end-products (RAGE) gene with susceptibility and prognosis of heart failure.
    Cohen CR; Diel VB; La Porta VL; Rohde LE; Biolo A; Clausell N; Dos Santos KG
    Gene; 2012 Nov; 510(1):7-13. PubMed ID: 22964273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between the RAGE gene -374T/A, -429T/C polymorphisms and diabetic nephropathy: a meta-analysis.
    Shi Z; Lu W; Xie G
    Ren Fail; 2015 Jun; 37(5):751-6. PubMed ID: 25707513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The -429 T/C and -374 T/A gene polymorphisms of the receptor of advanced glycation end products gene (RAGE) are not risk factors for coronary artery disease in Slovene population with type 2 diabetes.
    Kirbis J; Milutinović A; Steblovnik K; Teran N; Terzić R; Zorc M
    Coll Antropol; 2004 Dec; 28(2):611-6. PubMed ID: 15666591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of -374T/A polymorphism of receptor for advanced glycation end products (RAGE) gene in Turkish diabetic and non-diabetic patients with coronary artery disease.
    Kucukhuseyin O; Aydogan HY; Isbir CS; Isbir T
    In Vivo; 2009; 23(6):949-54. PubMed ID: 20023238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The promoter polymorphisms of receptor for advanced glycation end products were associated with the susceptibility and progression of sepsis.
    Shao Y; Shao X; He J; Cai Y; Zhao J; Chen F; Tao H; Yin Z; Tan X; He Y; Lin Y; Li K; Cui L
    Clin Genet; 2017 Apr; 91(4):564-575. PubMed ID: 27172264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAGE gene polymorphism and environmental factor in the risk of oral cancer.
    Su S; Chien M; Lin C; Chen M; Yang S
    J Dent Res; 2015 Mar; 94(3):403-11. PubMed ID: 25582438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor for advanced glycation end products (RAGE) gene polymorphism and cardiovascular disease in end-stage renal disease patients.
    Buraczynska M; Zaluska W; Buraczynska K; Markowska-Gosik D; Ksiazek A
    Hum Immunol; 2015 Nov; 76(11):843-8. PubMed ID: 26429324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association analysis of -429T/C and -374T/A polymorphisms of receptor of advanced glycation end products (RAGE) gene in Malaysian with type 2 diabetic retinopathy.
    Ng ZX; Kuppusamy UR; Tajunisah I; Fong KC; Chua KH
    Diabetes Res Clin Pract; 2012 Mar; 95(3):372-7. PubMed ID: 22154374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The functional -374T/A polymorphism of the receptor for advanced glycation end products may modulate Crohn's disease.
    Däbritz J; Friedrichs F; Weinhage T; Hampe J; Kucharzik T; Lügering A; Broeckel U; Schreiber S; Spieker T; Stoll M; Foell D
    Am J Physiol Gastrointest Liver Physiol; 2011 May; 300(5):G823-32. PubMed ID: 21311028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of RAGE gene polymorphism with vascular complications in Indian type 2 diabetes mellitus patients.
    Tripathi AK; Chawla D; Bansal S; Banerjee BD; Madhu SV; Kalra OP
    Diabetes Res Clin Pract; 2014 Mar; 103(3):474-81. PubMed ID: 24418399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms of the receptor for advanced glycation end products as vasculopathy predictor in sickle cell disease.
    Safwat NA; ELkhamisy MM; Abdel-Wahab SEA; Hamza MT; Boshnak NH; Kenny MA
    Pediatr Res; 2021 Jan; 89(1):185-190. PubMed ID: 32544923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 63bp deletion in the promoter of rage correlates with a decreased risk for nephropathy in patients with type 2 diabetes.
    Rudofsky G; Isermann B; Schilling T; Schiekofer S; Andrassy M; Schneider JG; Morcos M; Humpert PM; Sayed AA; Witte S; Renn W; Pfohl M; Hamann A; Nosikov V; Schleicher E; Häring HU; Rudofsky G; Ritz E; Nawroth PP; Bierhaus A
    Exp Clin Endocrinol Diabetes; 2004 Mar; 112(3):135-41. PubMed ID: 15052533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.